16 Chronic Internal Carotid Artery Occlusion



10.1055/b-0038-162145

16 Chronic Internal Carotid Artery Occlusion

Nina Z. Moore, Andrew M. Bauer, and Peter A. Rasmussen


Abstract


Chronic internal carotid artery occlusion can be a difficult pathology to treat as the related recurrent transient ischemic attacks, hypoperfusion, and strokes lead to a progressive clinical decline even for patients on the best medical management. In this chapter, the role of medical management, endovascular intervention, and surgical bypass is discussed and the controversies that surround these management strategies are explored. The extracranial carotid–internal carotid (EC-IC) bypass is a technique that continues to be a point of contention in the chronic internal carotid artery occlusion treatment world. The debate of the usefulness of the EC-IC bypass derives from what is currently known in the literature and the dilemma of managing persistently symptomatic patients despite what is considered the standard optimal medical therapy. The assessment of patients with chronic internal carotid artery occlusion is discussed to help characterize the factors that impact clinical progression and may help identify a subset of patients who could potentially benefit from surgical intervention. This chapter offers an algorithm for assessing chronic internal carotid occlusion and delves into the utility of surgical and endovascular treatment strategies. The technique of the EC-IC bypass as well as common complications and their avoidance is described in detail. There is still much to be learned about the physiology of chronic carotid occlusion and the impact of fluid dynamic alterations on neurologic function preservation. Further understanding of this pathology may someday lead to a higher rate of success with treatment strategies.




Introduction


Chronic internal carotid artery (ICA) occlusion resulting from atherosclerotic disease causes approximately 10% of transient ischemic attacks (TIAs) and 15 to 25% of ischemic strokes in the ipsilateral carotid territory. When compared to acute ICA occlusion presenting with acute onset of severe neurological symptoms, these patients often present with a more gradual course of decline in cognitive function and have recurrent disabling TIAs, symptomatic hypoperfusion, and recurrent strokes. In addition, even in the absence of obvious neurological events, serial imaging may review progressive cerebral volume loss. The 2-year risk of ipsilateral ischemic stroke is 10 to 15% even while the patient is on best medical therapy. In 1969, Yasargil first described the direct extracranial–intracranial (EC-IC) bypass procedure, anastomosing the superficial temporal artery (STA) to a distal branch of the middle cerebral artery (MCA) to augment hemispheric perfusion. Since that time, few neurosurgical procedures have been more controversial. Two large randomized controlled trials have failed to show benefit of surgery over medical therapy, with stroke as the primary end point; however, there still exists a subset of patients who may benefit from surgical revascularization.


Major controversies in decision making addressed in this chapter include:




  1. Should chronic ICA occlusion be treated?



  2. Should chronic symptomatic ICA occlusion be treated medically, endovascularly, or by EC-IC bypass?



  3. The role of open endovascular techniques.



  4. The role of low- and high-flow EC-IC bypass.



Whether to Treat


There is an extensive body of literature available on atherosclerotic occlusive disease of the carotid artery. There is overwhelming support for carotid endarterectomy and endovascular angioplasty and stenting in the setting of symptomatic severe carotid stenosis. The management of carotid occlusion is somewhat less clear. The occurrence of symptoms with chronic carotid occlusion theoretically relates primarily to the adequacy of the circle of Willis and the cerebral autoregulatory system such that perfusion may be preserved in the face of reduced inflow from the occluded carotid artery.


It is generally accepted and supported by guidelines that all patients with severe atherosclerotic disease and carotid stenosis or occlusion, regardless of neurological symptoms, should be treated with aggressive medical management ( 1 , 3, 5 in algorithm ). This includes treatment of hypertension (goal blood pressure below 140/90 mm Hg), smoking cessation, hyperlipidemia (goal low-density lipoprotein cholesterol less than 100 mg/dL), and diabetes (goal hemoglobin A1C less than 7.0%). Antiplatelet treatment with either aspirin (ASA) or clopidogrel is also recommended in these patients.

Algorithm 16.1 Decision-making algorithm for chronic internal carotid artery occlusion.

If symptoms persist despite best medical management, surgery can be considered. Surgical options generally consist of revascularization via either direct or indirect EC-IC bypass ( 6 in algorithm ). In our practice, the patients selected for surgical treatment must have persistent symptoms that are refractory to medical therapy and objective evidence of cerebral hypoperfusion, as discussed below (▶ Fig. 16.1 ).

Fig. 16.1 Internal carotid artery occlusion with hypoperfusion. Anteroposterior (AP) and lateral view of the left internal carotid artery demonstrating internal carotid occlusion with reconstitution through collateral flow. MRI perfusion demonstrating evidence of stroke in the diffusion-weighted image and a larger area of hypoperfusion in the mean transit time perfusion study.


Anatomical Considerations


The primary anatomical considerations are the adequacy of the external carotid artery (ECA) as a donor and the specific anatomy of the circle of Willis and collateral patterns. Patients who have atherosclerotic occlusion of the proximal ICA often also have disease in the proximal ECA. In these cases, ECA endarterectomy or stenting may be necessary prior to the intracranial anastomosis. In a few patients, we have seen distal collaterals to the proximally occluded ECA indicating patency of the STA and have utilized common carotid or subclavian to ECA bypass to revascularize the ECA prior to EC-IC bypass.


Generally, for a direct EC-IC bypass to remain patent, the STA should be at least 1 mm in diameter. If the STA is either very small or nonexistent, then indirect bypass via some variation of encephaloduralmyoarterialsynangiosis (EDAMS) can be attempted. We have not been as satisfied with the outcomes of indirect bypass procedures in the adult population with carotid occlusion as in younger patients with moyamoya.


The collateral patterns are very important in consideration of EC-IC bypass ( 3, 4, 5 in algorithm ). Angiography of both internal and external carotid arteries and the vertebral arteries should be obtained (see below). In some patients, the collaterals are good enough that there is no objective evidence of hypoperfusion and the cause of ongoing symptoms should then be reevaluated. Patients who have patent anterior and posterior communicating arteries may maintain relatively normal perfusion patterns in the hemisphere. Patients who do not have a complete circle of Willis often fill part of the supraclinoid segment via ECA collaterals to the ophthalmic or middle meningeal arteries. Care should be taken not to interrupt these collaterals at the time of craniotomy.



Pathophysiology


The vital functions of the brain are directly dependent on near continuous blood flow for the delivery of metabolic substrates. The brain, unlike other organ systems, has little intrinsic energy reserves and little capacity for repair once damaged. Studies have suggested that flow rates less than 15 mL/100 g/min sustained for more than 1 hour can cause permanent cellular injury and cell death. It is also known that flow below 18 mL/100 g/min for a short time during carotid endarterectomy results in near-uniform depression of electroencephalogram (EEG) tracings, suggestive of cellular dysfunction. It is flow rates in this range in a “penumbra” of the hemisphere that may lead to progressive infarction in chronic carotid occlusion. This is directly related to the collateral pattern and adequacy of perfusion pressure. Left untreated, hypoperfusion can lead to a cascade of abnormal cellular signaling and release of inflammatory markers that can lead to apoptosis and cell death.



Workup



Clinical Evaluation


All patients are evaluated by a vascular neurologist. Risk factors should be assessed as discussed earlier. Generally, prior to consideration of surgical intervention, these risk factors have been optimized ( 5 in algorithm ). Once risk factor modification has been undertaken, it is important to investigate the severity, frequency, and duration of symptoms. Patients with chronic hypoperfusion may have symptoms with exertion that may include aphasia, hemiparesis, or sensory disturbance. These symptoms may resolve with elevation of the blood pressure. Many patients have chronic, recurrent, disabling, TIAs or the classically described “limb-shaking” variety typical of hypoperfusion. Some patients have recurrent strokes in the watershed distribution between the anterior cerebral artery (ACA) and MCA or posterior cerebral artery (PCA). It is these patients with unrelenting symptoms that we target for intervention. It is important to remember that patients with neurological symptoms that are out of proportion to the strokes/stroke volume seen on imaging are at very high risk to progress to irreversible progressive infarction.

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

May 19, 2020 | Posted by in NEUROSURGERY | Comments Off on 16 Chronic Internal Carotid Artery Occlusion

Full access? Get Clinical Tree

Get Clinical Tree app for offline access